Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (1): 81-83    DOI: 10.12891/ceog3792.2018
Original Research Previous articles | Next articles
Midkine levels decrease in late preeclampsia
İ. İ. Arıkan1, *(), A.T. Çakır1
1 Department of Gynecology and Obstetrics, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Aim: The aim of this study was to determine midkine (MK) expression in women with preeclampsia (PE) compared with those in a normal pregnancy. Materials and Methods: This study included 45 patients with PE and 35 patients in a control group. Women with PE who had a diagnosis of preeclampsia before gestational week 34 were included in the early PE group (n = 20). Women diagnosed with PE after gestational week 34 were in the late PE group (n = 45). Serum MK levels were compared between the groups. Results: MK level was neither different between normotensive women and those with early PE nor was it different between the early and late PE groups. MK levels were significantly different between the normal pregnancy and late PE groups. The MK level decreased in the late PE group compared with that in the normal pregnancy group. Conclusion: Serum MK levels significantly decrease in late PE women compared with normally pregnant women.
Key words:  Midkine      Preeclamsia      Pregnancy     
Published:  10 February 2018     
*Corresponding Author(s):  İ. İ. Arıkan     E-mail:  driarikan@hotmail.com

Cite this article: 

İ. İ. Arıkan, A.T. Çakır. Midkine levels decrease in late preeclampsia. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 81-83.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3792.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I1/81

[1] H. Yolli, M.E. Demir, R. Yildizhan. Neutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 519-523.
[2] K. Chikazawa, K. Imai, T. Kuwata, K. Takagi. Prophylactic laparoscopic adnexal surgery with low-pressure CO2 insufflation for ovarian cysts during the late first trimester or second trimester of pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 537-540.
[3] J. A. Villarreal-Rodriguez, L. G. Mancillas Adame, J. Maldonado-Sanchez, A. Guzmán-López, O. R. Treviño-Montemayor, J. G. Gonzalez-Gonzalez, D. Saldívar-Rodríguez. A randomized controlled trial comparing acarbose vs. insulin therapy for gestational diabetes in individuals with inadequate glycemic control by diet alone[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 552-555.
[4] J. Ogawa, S. Suzuki. Risk factors of self-interruption of medications for mental disorders in pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 576-578.
[5] A. Daniilidis, G. Dryllis, G. Chorozoglou, M. Politou, R. Dampali, K. Dinas. Substitution of hemoglobin levels in pregnant women with iron supplement: A prospective randomized clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 579-583.
[6] Z.Y. Chang, R. Cao, R.C. Xu, Y. Cheng, Q.J. Wan. Pregnancy in a peritoneal dialysis patient undergoing intermittent peritoneal dialysis during the third trimester of pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 596-599.
[7] C.Y. Huang, T.C. Chao, H.C. Chien, Y.L. Liu. Outcome of shared decision-making in a patient with primary herpes gingivostomatitis during pregnancy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 604-606.
[8] G.L. Liu, S.C. He, W.J. Shan, H.Y. Chen. Repetitive hydatidiform mole in the cesarean scar: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 607-610.
[9] K. Nakanishi, Y. Oishi, T. Miyamoto, E. Nakamura, K. Murakami, M. Ono, A. Nozawa, S. Kitamura, K. Sengoku. Anti-E alloimmunization in a pregnancy with a low antibody titer[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 614-616.
[10] F. Wang, Z.X. Liang, W.R. Mao, S.N. He, D.Q. Chen. Influence of pre-pregnancy body mass index and gestational weight gain in twin pregnancies on blood glucose, serum lipid and perinatal outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 376-382.
[11] G. Keren, G. Ayala. Factors associated with hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 391-395.
[12] H. Cokmez, C. Bayram. Pituitary apoplexy developing during pregnancy: escape from the verge of death[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 429-431.
[13] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[14] Y.Q. Xu, X. L. Chen, S. Zhao, P. W. Chen, X. M. Yin, S. Y. Xiong, Z. Ding, F. Xiong, X. H. Yang. OEIS complex (omphalocele-exstrophy-imperforate anus-spinal defects) in monozygotic twins: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 154-158.
[15] H.F. Zhang, J. Zhang, D. Yang, S.N. Li. Clinical analysis of atrial fibrillation in pregnant women[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 174-178.
No Suggested Reading articles found!